English language citations reporting complications of arteriovenous access for hemodialysis are critically reviewed and discussed. Venous hypertension, arterial steal syndrome, and high-output cardiac ...

The primary patency of the entire access circuit at six months in patients with an AV fistula and AV graft were 72.6% and 68.8%, respectively. Favorable Industry Prospects of MMSI ...

Venova Medical announced the completion of patient enrollment for the company’s VENOS-2 early feasibility study. Accordi ...

Venova Medical, a privately held company developing a next generation technology for the creation of percutaneous arteriovenous fistulas (pAVF) for hemodialysis access, today announced the successful ...

Accesses placed included 20 radiocephalic AVF, 8 brachiobasilic AVF, 8 brachiocephalic AVF, 2 arteriovenous grafts ... and may allow more options for access placements. However, these patients ...

Moreover, the primary patency of the entire access circuit at six months was 72.6% for AV fistula patients and 68.8% for those with an AV graft. "Merit Medical’s WRAPSODY device gains FDA ...

musc.edu Background Dural arteriovenous fistulae (dAVF) of the anterior fossa have a malignant course ... We describe a transvenous approach for Onyx embolization of these lesions that relies on ...

Last month, Markovic revealed she was undergoing surgery for an arteriovenous malformation - an abnormal tangle of blood vessels that looks like a bird’s nest. Last month, Markovic revealed she was ...

Healthcare systems face challenges in meeting the growing demand for dialysis services due to critical gaps and shortcomings.